Skip to main navigation Skip to search Skip to main content

Chronic myelogenous leukemia‐derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a

Titus Kretzschmar*, Andreas Jeromin, Claudia Gietz, Wilfried Bautsch, Andreas Klos, Jörg Köhl, Gerhard Rechkemmer, Dieter Bitter‐Suermann

*Corresponding author for this work

Abstract

The receptor for the inflammatory peptide C3a has scarcely been examined on human cells. This work demonstrates that human tumor‐derived basophilic granulocytes express C3a receptors, and presents parts of the hitherto unknown C3a‐signal transduction. When incubated with IL‐3, these cells specifically liberated histamine on C3a stimulation. Independent from IL‐3, 240000 ± 100000 receptors per cell with a Kd of 5.6 ± 0.9 nM were determined. (Ca2+)j increased from 120 ± 35 nM to 300 ± 80 nM after a C3a challenge, as measured by digital imaging fluorescence microscopy, and rested at its basal level in the presence of C3a‐desArg, the immediate catabolic product of C3a in vivo. This (Ca2+ )i increase could be completely desensitized homologously by C3a as well as inhibited by up to 75% by pertussis toxin. Thus, tumor‐derived basophils are suitable for cloning of the human C3a receptor.

Original languageEnglish
JournalEuropean Journal of Immunology
Volume23
Issue number2
Pages (from-to)558-561
Number of pages4
ISSN0014-2980
DOIs
Publication statusPublished - 01.02.1993

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Chronic myelogenous leukemia‐derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a'. Together they form a unique fingerprint.

Cite this